These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7471522)

  • 21. The effects of intraperitoneal injection of 6-hydroxydopamine on the turnover and the levels of the brain catecholamines and the levels of plasma corticosterone in rats.
    Kawa A; Kamisaki T; Ariyama T; Kawabata T; Maeda Y; Okamoto O; Kanehisa T
    Clin Exp Pharmacol Physiol; 1979; 6(2):123-8. PubMed ID: 421367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool.
    Soares-da-Silva P; Davidson R
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):253-7. PubMed ID: 3927177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central noradrenergic involvement in yohimbine excitation of acoustic startle: effects of DSP4 and 6-OHDA.
    Kehne JH; Davis M
    Brain Res; 1985 Mar; 330(1):31-41. PubMed ID: 3921192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Onset of hypertension in spontaneously hypertensive rats despite the depletion of spinal cord catecholamines.
    Loewy AD; McKellar S; Swensson EE; Panneton WM
    Brain Res; 1980 Mar; 185(2):449-54. PubMed ID: 7357439
    [No Abstract]   [Full Text] [Related]  

  • 25. Seizure susceptibility after depletion of spinal or cerebellar noradrenaline with 6-OHDA.
    Mason ST; Corcoran ME
    Brain Res; 1979 Apr; 166(2):418-21. PubMed ID: 427596
    [No Abstract]   [Full Text] [Related]  

  • 26. Importance of spinal noradrenergic pathways in cardiovascular reflexes and central actions of clonidine and alpha-methyldopa in the rabbit.
    Elghozi JL; Head GA; Wolf WA; Anderson CR; Korner PI
    Brain Res; 1989 Oct; 499(1):39-52. PubMed ID: 2508991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Ca2+ antagonists on cardiovascular responses to posterior hypothalamic stimulation in the rat.
    Eferakeya AE; Osunkwo UA
    Clin Exp Pharmacol Physiol; 1984; 11(6):563-9. PubMed ID: 6536417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletion.
    Post C; Persson ML; Archer T; Minor BG; Danysz W; Sundström E
    Eur J Pharmacol; 1987 May; 137(1):107-16. PubMed ID: 2886347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal chemical sympathectomy: functional control of denervation of the vascular system and tissue noradrenaline level in the rat after 6-hydroxydopamine.
    Provoost AP; Bohus B; de Jong W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(4):353-63. PubMed ID: 4375255
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of dopamine in the development of spontaneous hypertension.
    van den Buuse M; Versteeg DH; de Jong W
    Hypertension; 1984; 6(6 Pt 1):899-905. PubMed ID: 6519747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 6-hydroxydopamine at birth on the development of hypertension in the rat.
    Finch L; Cohen M; Horst WD
    Life Sci; 1973 Nov; 13(10):1403-10. PubMed ID: 4762607
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of hypertension in the SH rat: effects of differential central catecholamine depletion.
    Erinoff L; Heller A; Oparil S
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):748-54. PubMed ID: 1208597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of apontaneously hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):166-76. PubMed ID: 666457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
    Suenaga N; Yamada K; Fukuda T
    Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
    Fobes JL; Olds ME
    Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of central catecholamines in the control of blood pressure and drinking behavior.
    Gordon FJ; Brody MJ; Fink GD; Buggy J; Johnson AK
    Brain Res; 1979 Dec; 178(1):161-73. PubMed ID: 497858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 6-hydroxydopamine treatment on TSH secretion in basal and cold-stimulated conditions in the rat.
    Schettini G; Quattrone A; Di Renzo G; Lombardi G; Preziosi P
    Eur J Pharmacol; 1979 Jun; 56(1-2):153-7. PubMed ID: 467504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of effect of protriptyline on the 6-hydroxydopamine-induced noradrenaline depletion in the rat spinal cord.
    Pernevi P; Trolin G
    J Pharm Pharmacol; 1974 Dec; 26(12):978-9. PubMed ID: 4156866
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny.
    Sachs C; Jonsson G
    Brain Res; 1975 Dec; 99(2):277-91. PubMed ID: 1182547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.